0000950123-17-001390.txt : 20170210
0000950123-17-001390.hdr.sgml : 20170210
20170210100110
ACCESSION NUMBER: 0000950123-17-001390
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20161231
FILED AS OF DATE: 20170210
DATE AS OF CHANGE: 20170210
EFFECTIVENESS DATE: 20170210
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Fund Management, LLC
CENTRAL INDEX KEY: 0001637359
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16844
FILM NUMBER: 17590182
BUSINESS ADDRESS:
STREET 1: 185 DARTMOUTH STREET, SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617 502 6538
MAIL ADDRESS:
STREET 1: 185 DARTMOUTH STREET, SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Omega Fund Management (US) Inc.
DATE OF NAME CHANGE: 20150320
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001637359
XXXXXXXX
12-31-2016
12-31-2016
Omega Fund Management, LLC
185 Dartmouth Street, Suite 502
Boston
MA
02116
13F HOLDINGS REPORT
028-16844
N
Anne-Mari Paster
Chief Financial Officer, Omega Fund Management, LLC
617-502-6538
/s/ Anne-Mari Paster
Boston
MA
02-09-2017
0
12
123236
false
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Cidara Therapeutics
Common Stock
171757107
5149
495050
SH
SOLE
495050
0
0
CymaBay Therapeutics
Common Stock
23257D103
522
301477
SH
SOLE
301477
0
0
Dicerna Pharmaceuticals
Common Stock
253031108
644
223457
SH
SOLE
223457
0
0
Editas Medicine
Common Stock
28106W103
1074
66162
SH
SOLE
66162
0
0
Egalet
Common Stock
28226B104
22108
2889926
SH
SOLE
2889926
0
0
ESSA Pharma
Common Stock
29668H104
3716
1696969
SH
SOLE
1696969
0
0
FibroGen
Common Stock
31572Q808
17595
822175
SH
SOLE
822175
0
0
Juno Therapeutics
Common Stock
48205A109
23176
1229512
SH
SOLE
1229512
0
0
Nabriva Therapeutics
Sponsored ADR
62957M104
6830
1145890
SH
SOLE
1145890
0
0
Paratek Pharmaceuticals
Common Stock
699374302
40046
2600410
SH
SOLE
2600410
0
0
Pieris Pharmaceuticals
Common Stock
720795103
2376
1697384
SH
SOLE
1697384
0
0
Proteon Therapeutics
Common Stock
74371L109
0
0
SH
SOLE
0
0
0